The HPV test has similar sensitivity but more overdiagnosis than the Pap test--a randomised health services study on cervical cancer screening in Finland.
about
Application of the Carolina Framework for Cervical Cancer PreventionEvolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India.Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.Harms of cervical cancer screening in the United States and the Netherlands.The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time.Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.The four steps in the prevention of human papillomavirus-associated neoplasia: considerations for preventive measures, screening, disease impact, and potential overtreatments in HPV-related pathology.Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre-invasive phase.The clinical performance of computer-assisted liquid-based cytology, primary hrHPV screening, and cotesting at a Turkish Tertiary Care Hospital.Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan.Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China
P2860
Q33610692-0AD124CE-EEF0-4935-ADB8-05BE259D204FQ35889801-24C28419-3B4C-49A3-B633-76A28F7F7430Q37696468-60575BFA-6ED2-48C0-9531-606BCA5E0F1EQ38660469-0E84B43C-1CC7-4281-A9FF-4255227868EBQ39172644-C4D3080B-2922-42F9-8A36-53B3701B52A9Q39200604-5BFA604C-0DBE-42F3-A55D-047D42C67114Q40101106-51319379-BA72-477B-94F8-7110588D8607Q42274467-5C0E4D99-D102-4C7F-8428-28F9DD9E5E04Q45834602-1C2833DA-DC92-45D1-B4D6-372000B24754Q48198042-E5A26D8E-569F-4819-86DD-E6DB875AC4E9Q48521545-FCA5997F-750A-4D17-BE0B-EA10A75C99F2Q52655995-7ED98D56-F9E7-40C4-8512-D03705A60258Q58579986-3CA6AF5C-C323-45A0-93FC-51158054A9DB
P2860
The HPV test has similar sensitivity but more overdiagnosis than the Pap test--a randomised health services study on cervical cancer screening in Finland.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The HPV test has similar sensi ...... l cancer screening in Finland.
@en
The HPV test has similar sensi ...... l cancer screening in Finland.
@nl
type
label
The HPV test has similar sensi ...... l cancer screening in Finland.
@en
The HPV test has similar sensi ...... l cancer screening in Finland.
@nl
prefLabel
The HPV test has similar sensi ...... l cancer screening in Finland.
@en
The HPV test has similar sensi ...... l cancer screening in Finland.
@nl
P2093
P2860
P356
P1476
The HPV test has similar sensi ...... l cancer screening in Finland.
@en
P2093
Jussi Tarkkanen
Laura Kotaniemi-Talonen
Maarit Leinonen
Matti Hakama
Nea Malila
Pekka Laurila
P2860
P304
P356
10.1002/IJC.27850
P577
2012-10-12T00:00:00Z